Cancer News and Research

Latest Cancer News and Research

Personal Genome Diagnostics’ pan-cancer assay being used in new clinical trial

Personal Genome Diagnostics, Inc., a leader in cancer genomics and pioneer in liquid biopsy, today reported that its non-invasive, pan-cancer plasma assay is being used in an important new clinical trial, Nivolumab, Ipilimumab in Patients With Hyper Mutated Cancers Detected in Blood, led by the Cancer Research Institute and Canadian Cancer Trials Group.

9 Oct 2018

New DNA test can predict adult heart attack risk much earlier in life

People at high risk of a heart attack in adulthood could be spotted much earlier in life with a one-off DNA test, according to new research part-funded by the British Heart Foundation and published today in the Journal of the American College of Cardiology.

9 Oct 2018

Lumitron HyperVIEW system set to redefine diagnosis and treatment of cancer

At an exclusive event held at University of California, Irvine Applied Innovation Center, Lumitron Technologies, Inc. celebrated its arrival in the university's prestigious Research Park and introduced the gathered luminaries to the HyperVIEW system.

9 Oct 2018

'Supercharged' immune cells could help fight cancer

A type of 'supercharged' immune cell could be mass-produced to help fight cancer.

9 Oct 2018

CDx Diagnostics announces WATS3D data demonstrating crypt dysplasia as risk factor for esophageal cancer

CDx Diagnostics, an innovator in computer synthesized, three dimensional tissue analysis for the early detection and surveillance of Barrett’s esophagus, today announced new data for WATS3D, or Wide Area Transepithelial Sampling with 3D Tissue Analysis, demonstrating the clinical significance of crypt dysplasia as an important risk factor for progression to high-grade esophageal dysplasia or esophageal cancer.

9 Oct 2018

Spurred by convenience, millennials often spurn the ‘family doctor’ model

Calvin Brown doesn’t have a primary care doctor — and the peripatetic 23-year-old doesn’t want one.

9 Oct 2018

Children with asthma have higher risk of obesity

Toddlers with asthma are more likely to become obese children, according to an international study led by USC scientists.

9 Oct 2018

Veracyte to present data demonstrating potential of Envisia Genomic Classifier to improve ILD diagnosis

Veracyte, Inc. announced the presentation of data demonstrating that the Envisia Genomic Classifier can help physicians more confidently diagnose interstitial lung disease (ILD), including idiopathic pulmonary fibrosis (IPF), without the need for surgery.

8 Oct 2018

Arcus Biosciences announces presentation of final results from Phase 1 study of AB928 at ESMO 2018

Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company focused on creating innovative cancer immunotherapies, today announced that it will present final results from the Phase 1 study of AB928, its dual adenosine receptor antagonist, in healthy volunteers during a poster display session at the European Society of Medical Oncology 2018 Congress, being held October 19-23, 2018, in Munich, Germany.

8 Oct 2018

Brexit will seriously harm UK cancer research, experts say

Cancer experts warn that Brexit will seriously harm UK cancer research and could trigger a manpower crisis that will negatively affect the health of our citizens.

8 Oct 2018

Cutting-edge precision medicine spreading from specialist cancer units to community setting

Nearly 1 in 4 patients with advanced cancer, treated at Comprehensive Cancer Care Network centers in the US, are receiving innovative drugs matched to DNA mutations in their tumors.

8 Oct 2018

Study finds suboptimal antithrombotic care in AFib patients with cancer history

Atrial fibrillation patients with a history of cancer are less likely to see a cardiologist or fill anticoagulant prescriptions compared with AFib patients who never had cancer, according to a study in the Journal of the American College of Cardiology.

8 Oct 2018

Neoadjuvant clinical trial of immune checkpoint blockade for melanoma patients yields high response rate

Combination checkpoint blockade before surgery (neoadjuvant therapy) produced a high response rate among patients with high-risk stage 3 melanoma, with nearly half having no sign of disease at surgery, but a high incidence of side effects caused the trial to be closed early.

8 Oct 2018

Researchers design new method to pinpoint genetic differences between species

Why do naked mole rats live up to 31 years, when distantly related lab mice are lucky to make it to four? How is the aquatic axolotl capable of regenerating limbs, jaws, spines and even brains when frogs can only regrow tails as tadpoles? How can these difference be exploited for the benefit of human health?

8 Oct 2018

New genome editing tool used to heal genetic disease

Parents of newborns may be familiar with the metabolic disorder phenylketonuria: in Switzerland, all newborn babies are screened for this genetic disease.

8 Oct 2018

Beyond BRCA: Epigenetic Silencing in Breast Cancer

An interview with Professor William Newman, discussing his recent discovery in the field of breast cancer research, and the options that this will provide for women who have a family history of breast cancer but test negative for BRCA1/2 mutations.

8 Oct 2018

NCCN adds COPIKTRA capsules to NCCN Guidelines for follicular lymphoma

Verastem, Inc., focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients, today announced that the National Comprehensive Cancer Network added COPIKTRA (duvelisib) capsules to the Clinical Practice Guidelines in Oncology (NCCN Guidelines) for follicular lymphoma.

8 Oct 2018

New epigenetic screening method could improve cancer detection

Researchers have found a better way to determine the epigenetic code of DNA for the identification of disease, using enzymes instead of bisulphite.

8 Oct 2018

Researchers use CRISPR-Cas9 to prevent congenital disease in utero

Researchers have successfully used prenatal gene editing (CRISPR-Cas9) to prevent a fatal metabolic disorder in an animal model.

8 Oct 2018

Joint research team discovers potential new treatment for severe malaria

Scientists from Massachusetts Institute of Technology, Singapore-MIT Alliance for Research and Technology and Nanyang Technological University, Singapore have discovered a potential treatment that could be effective against severe malaria and even drug-resistant malaria.

8 Oct 2018